EP0853486A3 - Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes - Google Patents

Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes

Info

Publication number
EP0853486A3
EP0853486A3 EP96932773.3A EP96932773A EP0853486A3 EP 0853486 A3 EP0853486 A3 EP 0853486A3 EP 96932773 A EP96932773 A EP 96932773A EP 0853486 A3 EP0853486 A3 EP 0853486A3
Authority
EP
European Patent Office
Prior art keywords
viral
aids
cancer
treatment
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP96932773.3A
Other languages
German (de)
English (en)
Other versions
EP0853486A2 (fr
EP0853486A4 (fr
Inventor
Samir Chachoua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB1996/001115 external-priority patent/WO1997011667A2/fr
Publication of EP0853486A3 publication Critical patent/EP0853486A3/fr
Publication of EP0853486A2 publication Critical patent/EP0853486A2/fr
Publication of EP0853486A4 publication Critical patent/EP0853486A4/fr
Withdrawn legal-status Critical Current

Links

EP96932773A 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes Withdrawn EP0853486A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US428195P 1995-09-25 1995-09-25
US4281P 1995-09-25
PCT/IB1996/001115 WO1997011667A2 (fr) 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes

Publications (3)

Publication Number Publication Date
EP0853486A3 true EP0853486A3 (fr) 1997-06-12
EP0853486A2 EP0853486A2 (fr) 1998-07-22
EP0853486A4 EP0853486A4 (fr) 2001-09-26

Family

ID=21710013

Family Applications (2)

Application Number Title Priority Date Filing Date
EP96932773A Withdrawn EP0853486A4 (fr) 1995-09-25 1996-09-25 Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes
EP96931214A Withdrawn EP0858327A2 (fr) 1995-09-25 1996-09-25 Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP96931214A Withdrawn EP0858327A2 (fr) 1995-09-25 1996-09-25 Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies

Country Status (5)

Country Link
EP (2) EP0853486A4 (fr)
JP (1) JPH11514990A (fr)
AU (2) AU7143196A (fr)
CA (2) CA2233015A1 (fr)
WO (2) WO1997011667A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6384259B1 (en) 1998-11-16 2002-05-07 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and dosage form
ATE355846T1 (de) * 1999-10-04 2007-03-15 John Carter Pharmazeutische zusammensetzung, die kupfer, salicylsäure und vitamin c enthält
US7927612B2 (en) 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
US6811788B2 (en) 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
FR2825923B1 (fr) * 2001-06-15 2006-04-07 Oreal Inhibiteur de no-synthase et utilisations
KR20030077743A (ko) * 2002-03-26 2003-10-04 변현규 In½
US7629333B2 (en) 2002-03-29 2009-12-08 Medimmune, Llc Stable amorphous amifostine compositions and methods for the preparation and use of same
AU2002353346A1 (en) * 2002-09-10 2004-04-30 Samir Chachoua Induced remission therapy
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
CN101138634A (zh) 2006-09-07 2008-03-12 于保法 用于治疗肿瘤的组合物
WO2009070788A1 (fr) 2007-11-30 2009-06-04 The Ramaekers Family Trust Compositions et procédés d'amélioration de la fertilité
US20110311557A1 (en) * 2009-02-11 2011-12-22 Martin Heath Bluth Reciprocal serum/plasma exchange for the treatment of cancer
SG11201704175WA (en) 2014-11-26 2017-06-29 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228127A (en) * 1978-10-06 1980-10-14 International Radioimmune Systems, Inc. Kit for detecting human chorionic gonadotropin
US4952607A (en) * 1982-05-27 1990-08-28 International Copper Research Association, Inc. Copper complex for treating cancer
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors
US5310653A (en) * 1989-10-24 1994-05-10 Board Of Regents, The University Of Texas System Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
US5488042A (en) * 1992-03-13 1996-01-30 Arch Development Corporation Method for protection against genotoxic mutagenesis
DE4236069A1 (de) * 1992-10-26 1994-04-28 Werner Dr Bergmann Arzneimittel, insbesondere für orale Einnahme
WO1994028934A1 (fr) * 1993-06-07 1994-12-22 Center For Special Immunology Traitement adoptif de reconstitution immunitaire pour des patients atteints d'immunodeficiences acquises

Similar Documents

Publication Publication Date Title
EP0853486A4 (fr) Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes
AU3066992A (en) Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
EP0831873A4 (fr) Therapie combinatoire pour le traitement d'infections virales vih et autres
AU1102399A (en) Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU4322996A (en) Variants of human papilloma virus antigens
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU7694796A (en) Tumour vaccine and processes for preparing it
AU5135296A (en) Use of protealytic enzymes in the treatment of insect bites
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU3092995A (en) Breast specific genes and proteins
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2796799A (en) Amplification of gene transfer and gene therapy by controlled replication
AU8168898A (en) Interferon stimulating protein and uses thereof
HK1015268A (en) Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU3530395A (en) Treatment of viral infections
GEP20012489B (en) Use of Natural Human α-Interferon
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU3329895A (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof